Valuation: Star Scientific, Inc.

Market Cap 153K 135K 128K 116K 217K 14.73M 219K 1.53M 590K 7.51M 576K 563K 24.15M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.6M 16.64M 15.09M 28.35M 1.92B 28.51M 199M 76.96M 980M 75.13M 73.5M 3.15B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%+1.83%+63.28%+117.88% 1,055B
+0.40%+0.89%+49.70%+73.30% 654B
+1.12%+0.90%+19.58%+75.28% 467B
-1.36%-2.58%+38.77%+42.33% 348B
+1.34%+4.53%+22.56%+29.55% 275B
-0.48%-0.54%+12.66%+13.50% 258B
+0.82%+6.27%+52.50%+54.27% 224B
+0.88%+1.14%+35.22%+101.91% 187B
-0.30%-2.98%-28.24%-61.28% 171B
Average +0.33%+0.74%+29.56%+49.64% 404.26B
Weighted average by Cap. +0.36%+1.32%+39.82%+69.96%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.88M -32.03M -29.05M -54.57M -3.7B -54.88M -384M -148M -1.89B -145M -141M -6.06B -6.84M -6.02M -5.69M -5.16M -9.7M -657M -9.75M -68.16M -26.32M -335M -25.7M -25.14M -1.08B
Net Debt -45K -39.58K -37.43K -33.95K -63.75K -4.32M -64.12K -448K -173K -2.2M -169K -165K -7.08M 19.86M 17.46M 16.51M 14.98M 28.13M 1.91B 28.29M 198M 76.37M 973M 74.55M 72.94M 3.13B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-